Retrospective Evaluation of Patient Failure to Follow-up at a Community Based Headache Clinic

This study has been completed.
Sponsor:
Collaborator:
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Gary R. Kilgo, M. D., Kilgo Headache Clinic
ClinicalTrials.gov Identifier:
NCT00690989
First received: June 3, 2008
Last updated: March 31, 2015
Last verified: March 2015
  Purpose
This is a retrospective review of the records of patients seen at the Kilgo Headache Clinic in Alabama between 7/1/05 and 6/30/07. The goal of the study is to identify factors at the time of the initial office visit that can be used to predict failure to follow-up.

Condition
Headache

Study Type: Observational
Study Design: Time Perspective: Retrospective
Official Title: If You Build it, They Will Come; But Will They Return for Follow-up? A Retrospective Assessment of Potential Risk Factors for Patient Failure to Follow-up at a Community Based Headache Clinic

Resource links provided by NLM:


Further study details as provided by Kilgo Headache Clinic:

Primary Outcome Measures:
  • Adherence to followup recommendations [ Time Frame: 2 years ] [ Designated as safety issue: No ]

Enrollment: 200
Study Start Date: July 2005
Study Completion Date: June 2009
Primary Completion Date: June 2007 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Community based headache clinic population
Criteria

Inclusion Criteria:

  • Headache
  • Initial office visit between 7/1/05 and 6/30/07

Exclusion Criteria:

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00690989

Sponsors and Collaborators
Kilgo Headache Clinic
Merck Sharp & Dohme Corp.
Investigators
Principal Investigator: Gary R. Kilgo, M.D. Kilgo Headache Clinic
  More Information

Responsible Party: Gary R. Kilgo, M. D., Medical director, Kilgo Headache Clinic
ClinicalTrials.gov Identifier: NCT00690989     History of Changes
Other Study ID Numbers: MK-0974 IISP #35151 
Study First Received: June 3, 2008
Last Updated: March 31, 2015
Health Authority: United States: Institutional Review Board

Keywords provided by Kilgo Headache Clinic:
Headache
Adherence
Followup

Additional relevant MeSH terms:
Headache
Pain
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms

ClinicalTrials.gov processed this record on August 25, 2016